How SH - Search Results

1

Programmed death-ligand 1 expression and use of immune checkpoint inhibitors among patients with advanced non-small-cell lung cancer in a resource-limited country.

How SH, Tho LM, Liam CK, Hasbullah HH, Ho GF, Muhammad Nor I, Poh ME, Ho KF, Thiagarajan M, Samsudin A, Omar A, Ong CK, Pang YK, Soon SY. How SH, et al. Thorac Cancer. 2022 Jun;13(11):1676-1683. doi: 10.1111/1759-7714.14442. Epub 2022 May 3. Thorac Cancer. 2022. PMID: 35502623 Free PMC article.

2

Pleural effusions: role of commonly available investigations.

How SH, Chin SP, Zal AR, Liam CK. How SH, et al. Singapore Med J. 2006 Jul;47(7):609-13. Singapore Med J. 2006. PMID: 16810434 Free article.

3

Melioidosis: a potentially life threatening infection.

How SH, Liam CK. How SH, et al. Med J Malaysia. 2006 Aug;61(3):386-94: quiz 395. Med J Malaysia. 2006. PMID: 17240600 Free article. Review.

4

Serum cancer antigen 125 in patients with pleural effusions.

How SH, Liam CK, Jamalludin AR, Chin SP, Zal AB. How SH, et al. Med J Malaysia. 2006 Dec;61(5):558-63. Med J Malaysia. 2006. PMID: 17623956 Free article.

5

Defaulters among lung cancer patients in a suburban district in a developing country.

Ng TH, How SH, Kuan YC, Fauzi AR. Ng TH, et al. Among authors: how sh. Ann Thorac Med. 2012 Jan;7(1):12-5. doi: 10.4103/1817-1737.91556. Ann Thorac Med. 2012. PMID: 22347344 Free PMC article.

6

Bone mineral density in asthmatic patients on inhaled corticosteroids in a developing country.

Kuan YC, How SH, Azian AA, Liam CK, Ng TH, Fauzi AR. Kuan YC, et al. Among authors: how sh. Ann Thorac Med. 2012 Apr;7(2):69-73. doi: 10.4103/1817-1737.94522. Ann Thorac Med. 2012. PMID: 22558010 Free PMC article.

7

Epidermal growth factor receptor mutations in non- small cell lung cancers in a multiethnic malaysian patient population.

Liam CK, Leow HR, How SH, Pang YK, Chua KT, Lim BK, Lai NL, Kuan YC, Pailoor J, Rajadurai P. Liam CK, et al. Among authors: how sh. Asian Pac J Cancer Prev. 2014;15(1):321-6. doi: 10.7314/apjcp.2014.15.1.321. Asian Pac J Cancer Prev. 2014. PMID: 24528049 Free article.

8

Survival of lung cancer patients in a resource-limited country.

How SH, Ng TH, Kuan YC, Jamalludin AR, Fauzi AR. How SH, et al. Asia Pac J Clin Oncol. 2015 Sep;11(3):221-7. doi: 10.1111/ajco.12179. Epub 2014 Feb 27. Asia Pac J Clin Oncol. 2015. PMID: 24575820

9

First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study.

Wu YL, Zhou C, Liam CK, Wu G, Liu X, Zhong Z, Lu S, Cheng Y, Han B, Chen L, Huang C, Qin S, Zhu Y, Pan H, Liang H, Li E, Jiang G, How SH, Fernando MCL, Zhang Y, Xia F, Zuo Y. Wu YL, et al. Among authors: how sh. Ann Oncol. 2015 Sep;26(9):1883-1889. doi: 10.1093/annonc/mdv270. Epub 2015 Jun 23. Ann Oncol. 2015. PMID: 26105600 Free article. Clinical Trial.

10

Depressive Symptoms in Newly Diagnosed Lung Carcinoma: Prevalence and Associated Risk Factors.

Shahedah KK, How SH, Jamalludin AR, Mohd Faiz MT, Kuan YC, Ong CK. Shahedah KK, et al. Among authors: how sh. Tuberc Respir Dis (Seoul). 2019 Jul;82(3):217-226. doi: 10.4046/trd.2018.0048. Epub 2018 Dec 20. Tuberc Respir Dis (Seoul). 2019. PMID: 30841021 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters